Option chain shows key data for Envoy Medical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Envoy Medical.

Envoy Medical (NASDAQ:COCH) Stock, Option Chain

Envoy Medical

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

penny stocks tips 1

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

Envoy Medical, Inc. - Class A Common Stock

COCH

HYLN

SXTP

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying

Small Cap

Intraday Update

Movers

ADIL

AEYE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BHVN

BTCY

CENX

CMAX

DXYZ

EGIO

EXTR

HUBC

IMCC

INFA

KAVL

KUKE

LGVN

LOCL

MNDR

MRNS

NMRA

Nuveen California Dividend Advantage Municipal Fund 2

NXPL

ONVO

PROK

PSNY

QTTB

RARE

RENT

SNGX

SNPO

SPCB

SPWR

SRFM

SWVL

TCON

VERU

VIAO

WIRE

Shares of  Ultragenyx Pharmaceutical Inc.  (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

ARDX

ATUS

BDSX

BROG

BYRN

FAAS

GCTS

GNLN

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

INKT

JZXN

KRUS

Kintara Therapeutics, Inc. - Common Stock

KTRA

KZIA

LGVC

MDIA

NCNC

RELI

SBFM

SPOT

STIX

Tempest Therapeutics, Inc. - Common Stock

TPST

XXII

NIVF

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Envoy Medical Inc

Cochlear Ltd

<p>RBC Capital  analyst Sean Dodge   reiterates Sotera Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHC#NASDAQ">SHC</a>) with a Outperform and maintains $17 price target.</p>


Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Sotera Health, Maintains $17 Price Target

<p>B of A Securities  analyst Tal Liani   maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Neutral and raises the price target from $400 to $430.</p>


PANW

B of A Securities Maintains Neutral on Palo Alto Networks, Raises Price Target to $430

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage -3B Vs 2B Est.; 42B Prior

<p><a href="https://thebearcave.substack.com/p/problems-at-transdigm-tdg" title="https://thebearcave.substack.com/p/problems-at-transdigm-tdg">https://thebearcave.substack.com/p/problems-at-transdigm-tdg</a></p>


Short Sellers

Watching TransDigm; The Bear Cave Research Issues Report Titled "Problems at TransDigm"

<p>Deep-pocketed investors have adopted a bearish approach towards ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COP usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for ConocoPhillips. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 37% leaning bullish and 62% bearish. Among these notable options, 2 are puts, totaling $60,600, and 6 are calls, amounting to $730,955.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $135.0 for ConocoPhillips over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ConocoPhillips's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ConocoPhillips's substantial trades, within a strike price spectrum from $115.0 to $135.0 over the preceding 30 days.</p>
<h3>ConocoPhillips Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732203127_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$130.00</td>
<td>$450.0K</td>
<td align="right">61</td>
<td>1.8K</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$130.00</td>
<td>$116.1K</td>
<td align="right">61</td>
<td>2.2K</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$130.00</td>
<td>$59.4K</td>
<td align="right">61</td>
<td>375</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$3.0</td>
<td>$2.99</td>
<td>$3.0</td>
<td>$130.00</td>
<td>$47.1K</td>
<td align="right">61</td>
<td>2.4K</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$7.4</td>
<td>$7.05</td>
<td>$7.4</td>
<td>$115.00</td>
<td>$34.0K</td>
<td align="right">208</td>
<td>46</td>
</tr>
</tbody>
</table>
</p>
<h3>About ConocoPhillips</h3>
<p>ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.</p>
<h3>Present Market Standing of ConocoPhillips</h3>
<ul>
<li>Currently trading with a volume of 705,190, the COP's price is up by 1.46%, now at $115.09. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
<h3>What Analysts Are Saying About ConocoPhillips</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $139.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Neutral rating for ConocoPhillips, targeting a price of $132.<br />
&#x2A; An analyst from Susquehanna has decided to maintain their Positive rating on ConocoPhillips, which currently sits at a price target of $148.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on ConocoPhillips with a target price of $137. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ConocoPhillips options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Looking At ConocoPhillips's Recent Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Iris Energy</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IREN, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Iris Energy.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 41% bullish and 52%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $817,500, and 13 are calls, for a total amount of $738,926.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $6.0 to $18.0 for Iris Energy over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Iris Energy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Iris Energy's significant trades, within a strike price range of $6.0 to $18.0, over the past month.</p>
<h3>Iris Energy Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732203121_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.6</td>
<td>$1.55</td>
<td>$1.6</td>
<td>$9.00</td>
<td>$320.0K</td>
<td>5.4K</td>
<td>4.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.65</td>
<td>$1.55</td>
<td>$1.55</td>
<td>$9.00</td>
<td>$310.2K</td>
<td>5.4K</td>
<td>2.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.65</td>
<td>$1.6</td>
<td>$1.6</td>
<td>$9.00</td>
<td>$160.0K</td>
<td>5.4K</td>
<td>5.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.55</td>
<td>$1.45</td>
<td>$1.5</td>
<td>$18.00</td>
<td>$150.1K</td>
<td>8.9K</td>
<td>2.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$4.3</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$8.00</td>
<td>$120.5K</td>
<td>2.2K</td>
<td>295</td>
</tr>
</tbody>
</table>
</p>
<h3>About Iris Energy</h3>
<p>Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.</p>
<p>Following our analysis of the options activities associated with Iris Energy, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Iris Energy</h3>
<ul>
<li>Currently trading with a volume of 10,433,826, the IREN's price is down by -5.15%, now at $9.58. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 5 days.</li>
</ul>
<h3>Expert Opinions on Iris Energy</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $20.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $20. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Iris Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


IREN

Smart Money Is Betting Big In IREN Options

<p>Deep-pocketed investors have adopted a bearish approach towards Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DE usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 20 extraordinary options activities for Deere. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 35% leaning bullish and 45% bearish. Among these notable options, 16 are puts, totaling $779,083, and 4 are calls, amounting to $204,500.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $380.0 and $460.0 for Deere, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Deere's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Deere's whale trades within a strike price range from $380.0 to $460.0 in the last 30 days. </p>
<h3>Deere 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732203115_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$16.8</td>
<td>$14.9</td>
<td>$16.8</td>
<td>$420.00</td>
<td>$100.8K</td>
<td>1.5K</td>
<td align="right">176</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.0</td>
<td>$16.95</td>
<td>$17.0</td>
<td>$420.00</td>
<td>$85.0K</td>
<td>454</td>
<td align="right">260</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$16.65</td>
<td>$13.55</td>
<td>$14.79</td>
<td>$420.00</td>
<td>$81.1K</td>
<td>454</td>
<td align="right">310</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$18.75</td>
<td>$15.4</td>
<td>$18.75</td>
<td>$420.00</td>
<td>$65.6K</td>
<td>454</td>
<td align="right">85</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$16.35</td>
<td>$14.45</td>
<td>$16.35</td>
<td>$430.00</td>
<td>$52.3K</td>
<td>112</td>
<td align="right">163</td>
</tr>
</tbody>
</table>
</p>
<h3>About Deere</h3>
<p>Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry in their green and yellow livery. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 2,000 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.</p>
<p>After a thorough review of the options trading surrounding Deere, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Deere</h3>
<ul>
<li>With a trading volume of 1,145,107, the price of DE is up by 5.35%, reaching $426.62.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 0 days from now.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Deere with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


This Is What Whales Are Betting On Deere

<p>Bringing Extensive Financial Expertise To Support Growth And Enhance Shareholder Value</p>


Management

UAVS

AgEagle Aerial Systems Appoints Adrienne Anderson As Interim CFO

Market Summary

General

$BTC

NVDA

SNOW

Benzinga Market Summary: Nvidia Shares Fall After Earnings Report, Initial Jobless Claims Come In Below Estimates, Snowflake Stock Surges On Earnings Report, Bitcoin Rises Above $98,000

<p><a href="https://grizzlyreports.com/we-believe-sharkninja-inc-nyse-sn-is-a-china-hustle-based-on-rampant-looting-and-conflicts-of-interest-with-the-chinese-chairman/" title="https://grizzlyreports.com/we-believe-sharkninja-inc-nyse-sn-is-a-china-hustle-based-on-rampant-looting-and-conflicts-of-interest-with-the-chinese-chairman/">https://grizzlyreports.com/we-believe-sharkninja-inc-nyse-sn-is-a-china-hustle-based-on-rampant-looting-and-conflicts-of-interest-with-the-chinese-chairman/</a></p>


Watching Shares Of SharkNinja; Grizzly Research Issues Report On The Co. Titled, "We Believe SharkNinja, Inc is a China Hustle Based on Rampant Looting and Conflicts of Interest with the Chinese Chairman"

<p>Cannabis operator with vertical operations in Arizona and Ohio <strong>Vext Science, Inc</strong>. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/VEXT#CSE">VEXT</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VEXTF#OTCQX">VEXTF</a>) reported on its financial results Thursday for the period ended Sept. 30, 2024.</p>
<p>&#8220;Vext&#8217;s performance in the third quarter of 2024 was a testament to the team&#8217;s disciplined execution amid persistent macroeconomic headwinds,"<strong> Eric Offenberger, </strong>CEO of Vext, said. "Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we&#8217;re pleased to report that our economic unit volumes remain strong."</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40463152/vext-cannabis-co-s-q2-revenue-drops-over-8-yoy-but-top-cannabis-analyst-sees-ohio-market-as-majo">Vext Cannabis Co.&#8217;s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver</a></strong></p>
<ul>
<li><strong><em>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</em></strong></li>
</ul>
<h3 class="wp-block-heading">Q3 2024 Financial Highlights</h3>
<ul>
<li>Revenue totaled roughly $9 million, up from $8 million in the prior year's period.</li>
<li>Gross profit was $3.9 million, up from $2.8 million in the third quarter of last year.</li>
<li>Total operating expenses amounted to $5.2 million, up from $4.5 million in the corresponding quarter of 2023.</li>
<li>Adjusted EBITDA amounted to approximately $2.9 million, up from $1 million in the third quarter of 2023.</li>
<li>Net loss was $2.5 million, up from $1.8 million in the prior year's period.</li>
</ul>
<h3 class="wp-block-heading">Outlook</h3>
<p>The company noted that it's well-positioned to increase its Ohio footprint with an integrated approach.</p>
<p>Vext aims to open more dispensaries in Ohio by 2025–2026, anticipating reaching the state's dispensary cap of 8.</p>
<p><strong>Pablo Zuanic,</strong> senior analyst at Zuanic &amp; Associates initiated coverage of Vext Science with an Overweight rating earlier this year, highlighting the company&#8217;s significant growth potential.</p>
<p>Zuanic calculated that Vext has the most EBITDA torque among the twelve public multi-state operators (MSOs) in Ohio, projecting Vext&#8217;s EBITDA could grow six-fold by calendar 2026, taking calendar 2023 as the base year. Recreational marijuana sales launched across Ohio on <a href="https://www.benzinga.com/markets/cannabis/24/08/40172821/its-official-ohio-begins-recreational-cannabis-sales-on-tuesday-heres-where-and-how-you-know-the">Tuesday, Aug. 6.</a></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40761882/1b-in-26-days-this-marijuana-company-is-capitalizing-on-ohios-cannabis-surge"><strong>$1B In 26 Days: This Marijuana Company Is Capitalizing On Ohio's Cannabis Surge</strong></a></li>
</ul>


Cannabis

Earnings

Retail Sales

CSE:VEXT

VEXTF

Ohio's Weed Enthusiasts Help This Cannabis Company's Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA

<p>RBC Capital  analyst Steven Shemesh   maintains Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) with a Outperform and raises the price target from $162 to $189.</p>


RBC Capital Maintains Outperform on Williams-Sonoma, Raises Price Target to $189

<p>B of A Securities  analyst Robert Ohmes   maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Buy and lowers the price target from $195 to $160.</p>


B of A Securities Maintains Buy on Target, Lowers Price Target to $160

<p>RBC Capital  analyst Brad Erickson   maintains Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) with a Outperform and raises the price target from $190 to $245.</p>


RBC Capital Maintains Outperform on Wix.com, Raises Price Target to $245

<p>BMO Capital  analyst Michael Zaremski   maintains Kinsale Cap Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) with a Market Perform and raises the price target from $445 to $461.</p>


KNSL

BMO Capital Maintains Market Perform on Kinsale Cap Gr, Raises Price Target to $461

Deere CFO Says Expect Farm Fundamentals To Remain Depressed Globally In 2025; Executive Says Production Costs For Fy Came In Favorable, Primarily Due To YoY Improvements In Material And Freight Costs Across All Business Segments

<p>Barclays  analyst David Zazula   maintains Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) with a Underweight and raises the price target from $0.75 to $2.</p>


EVTL

Barclays Maintains Underweight on Vertical Aerospace, Raises Price Target to $2

<p>BMO Capital  analyst Michael Zaremski   maintains Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) with a Underperform and raises the price target from $13 to $15.</p>


LMND

BMO Capital Maintains Underperform on Lemonade, Raises Price Target to $15

<p>Barclays  analyst Matthew Bouley   maintains AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) with a Overweight and raises the price target from $53 to $58.</p>


AZEK

Barclays Maintains Overweight on AZEK Co, Raises Price Target to $58

<p>At the recent <strong><a href="https://cannabismarketspotlight.com/california/anaheim-november-12/">Cannabis Market Spotlight</a></strong> event in Anaheim, California, <strong>Department of Cannabis Control </strong>director <strong>Nicole Elliott</strong> addressed some of the state's pressing cannabis industry challenges, zeroing in on tax reform and hemp regulation as two priority areas. </p>
<p>As the state's top cannabis regulator, Elliott provided a window into the Department&#8217;s goals as it navigates an increasingly complex regulatory landscape while striving to support industry growth and public health objectives.</p>
<h3 class="wp-block-heading">Tackling Tax Challenges</h3>
<p>Elliott spoke to the ongoing challenges posed by the state's current tax framework for cannabis businesses. Acknowledging the financial burdens and inefficiencies that affect operators, she explained how these tax issues undermine the state's cannabis objectives.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/24/11/42111795/californias-cannabis-future-why-one-expert-believes-the-market-will-hold-strong">California&#8217;s Cannabis Future: Why One Expert Believes The Market Will Hold Strong</a></strong></p>
<p>"We know taxes will be an issue," Elliott noted, emphasizing the importance of constructive engagement between industry participants and legislators. She encouraged those in the cannabis space to approach the state legislature with clear, informed communication to help shape effective tax reforms.</p>
<h3 class="wp-block-heading">Hemp Regulation and Unregulated Market Enforcement</h3>
<p>Elliott also addressed the recent California court decision upholding restrictions on certain hemp products. While the California Department of Public Health manages hemp regulations, Elliott's department is involved in enforcing regulations within unregulated markets. Her team also serves as an advisor on cannabinoid products and regulatory standards. </p>
<p>"We are serving as a subject matter expert when it comes to cannabinoid products, cannabinoid regulations," she shared, describing the department's role in guiding policy that aligns with California's public health and regulatory goals.</p>
<p>At the event, Elliott's comments offered industry professionals insights into the state's regulatory priorities, signaling areas of focus and potential legislative action as they prepare for what lies ahead in 2025.</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/11/42111313/exclusive-fluent-launches-new-cannabis-concentrates-line-for-medical-marijuana-patients-in-florida">FLUENT Launches New Cannabis Concentrates Line For Medical Marijuana Patients In Florida</a></strong></li>
</ul>
<p><em>Image: AI-Generated Image</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Events

Exclusives

Interview

From Tax Woes To Hemp Rules: Department Of Cannabis Control's Nicole Elliott Outlines Regulatory Goals

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Envoy Medical</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/coch-stock-quote/"><strong>COCH</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Envoy Medical reported earnings per share of -27 cents. This was below the analyst estimate for EPS of -25 cents.</li><li>The company reported revenue of $68,000.</li><li>This was 17.58% worse than the analyst estimate for revenue of $82,500.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/coch-stock-earnings-envoy-medical-for-q2-of-2024/">COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024

Envoy Medical GAAP EPS of -$0.27

Lake Street analyst Frank Takkinen maintained a Buy rating on Envoy Medical (COCH – Research Report) today and set a price target of $6.00. The com...

Envoy Medical (COCH) Receives a Buy from Lake Street

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcutis Biotherapeutics (ARQT – Research Report) and...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim Fully Implanted Coc...

Envoy Medical receives FDA approval to initiate study for hearing device

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Butterfly Network (BFLY – Research Report) and Envoy...

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Envoy Medical (COCH)

Envoy Medical (COCH) announces a peer-reviewed publication in Otology & Neurotology, discussing early experiences with and highlighting potential b...

Envoy Medical announces publication on Acclaim CI

Reports Q3 revenue $56,000 vs. $80,000 last year. "The progress and accomplishments of late have been extremely important to Envoy Medical (COCH) a...

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

Envoy Medical GAAP EPS of -$0.37 misses by $0.11, revenue of $0.05M misses by $0.02M

Lake Street analyst Frank Takkinen reiterated a Buy rating on Envoy Medical (COCH – Research Report) today and set a price target of $6.00. The com...

Lake Street Sticks to Their Buy Rating for Envoy Medical (COCH)

ARQT

BFLY

Press Releases

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical's Esteem® Device

Envoy Medical to Present at the   LD Micro Main Event XVII

Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Comments

Envoy Medical

Envoy Medical (COCH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga